File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1200/JCO.2017.35.15_suppl.e21657
- WOS: WOS:000411932205190
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Conference Paper: Changes in the sleep-wake rhythm, sleep quality, mood, and quality of life of patients receiving treatment for lung cancer: A longitudinal study
Title | Changes in the sleep-wake rhythm, sleep quality, mood, and quality of life of patients receiving treatment for lung cancer: A longitudinal study |
---|---|
Authors | |
Issue Date | 2017 |
Publisher | American Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/ |
Citation | 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 02-07 June 2017, v. 35 n. suppl. 15, p. abstract no. e21657 How to Cite? |
Abstract | Background: Studies on the diurnal sleep–wake rhythm of patients with lung cancer have mostly examined patients cross-sectionally, whereas the effects of lung cancer treatment over time have rarely been considered. Through long-term longitudinal tracking of patients with lung cancer, this study examined changes in their sleep–wake rhythm, sleep quality, anxiety, depressive symptoms, fatigue, and quality of life (QoL) at various treatment stages. In addition, factors affecting their QoL were explored. Methods: Hierarchical linear modelling was adopted to analyze a convenience sample of 82 patients with lung cancer. The changes in their sleep–wake rhythm, sleep, mood (anxiety, depressive symptoms, and fatigue), and QoL were observed at five time points: prior to treatment and at weeks 6, 12, 24, and 48 after the start of the treatment. The effects of sex, age, cancer stage, treatment type, comorbidities, and time were controlled to determine the predictors of patients’ QoL. Results: The results showed that patients’ sleep–wake rhythms were poor before treatments. Compared with baseline, the sleep–wake rhythms of the patients significantly improved at week 48, and anxiety significantly improved at weeks 6, 12, 24, and 48. By contrast, their fatigue became exacerbated at weeks 8 and 48. Moreover, QoL improved significantly from week 6 until the end of the treatment period. QoL was negatively affected by poor sleep quality (β = −0.69, p = 0.00) and depressive symptoms (β = −2.59, p < 0.001) and positively affected by regular sleep–wake rhythms (β = 0.23, p = 0.001). Conclusions: Therefore, clinical healthcare professionals should focus more attention to the fatigue levels of patients with lung cancer before, during, and after treatment. Healthcare professionals may also need to provide such patients with health education regarding sleep hygiene and with emotional support to assist them in maintaining regular sleep–wake rhythms in order to improve their QoL. |
Persistent Identifier | http://hdl.handle.net/10722/275355 |
ISSN | 2023 Impact Factor: 42.1 2023 SCImago Journal Rankings: 10.639 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lin, CC | - |
dc.contributor.author | Chang, WP | - |
dc.date.accessioned | 2019-09-10T02:40:53Z | - |
dc.date.available | 2019-09-10T02:40:53Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 02-07 June 2017, v. 35 n. suppl. 15, p. abstract no. e21657 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | http://hdl.handle.net/10722/275355 | - |
dc.description.abstract | Background: Studies on the diurnal sleep–wake rhythm of patients with lung cancer have mostly examined patients cross-sectionally, whereas the effects of lung cancer treatment over time have rarely been considered. Through long-term longitudinal tracking of patients with lung cancer, this study examined changes in their sleep–wake rhythm, sleep quality, anxiety, depressive symptoms, fatigue, and quality of life (QoL) at various treatment stages. In addition, factors affecting their QoL were explored. Methods: Hierarchical linear modelling was adopted to analyze a convenience sample of 82 patients with lung cancer. The changes in their sleep–wake rhythm, sleep, mood (anxiety, depressive symptoms, and fatigue), and QoL were observed at five time points: prior to treatment and at weeks 6, 12, 24, and 48 after the start of the treatment. The effects of sex, age, cancer stage, treatment type, comorbidities, and time were controlled to determine the predictors of patients’ QoL. Results: The results showed that patients’ sleep–wake rhythms were poor before treatments. Compared with baseline, the sleep–wake rhythms of the patients significantly improved at week 48, and anxiety significantly improved at weeks 6, 12, 24, and 48. By contrast, their fatigue became exacerbated at weeks 8 and 48. Moreover, QoL improved significantly from week 6 until the end of the treatment period. QoL was negatively affected by poor sleep quality (β = −0.69, p = 0.00) and depressive symptoms (β = −2.59, p < 0.001) and positively affected by regular sleep–wake rhythms (β = 0.23, p = 0.001). Conclusions: Therefore, clinical healthcare professionals should focus more attention to the fatigue levels of patients with lung cancer before, during, and after treatment. Healthcare professionals may also need to provide such patients with health education regarding sleep hygiene and with emotional support to assist them in maintaining regular sleep–wake rhythms in order to improve their QoL. | - |
dc.language | eng | - |
dc.publisher | American Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/ | - |
dc.relation.ispartof | Journal of Clinical Oncology | - |
dc.title | Changes in the sleep-wake rhythm, sleep quality, mood, and quality of life of patients receiving treatment for lung cancer: A longitudinal study | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Lin, CC: lincc@hku.hk | - |
dc.identifier.authority | Lin, CC=rp02265 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1200/JCO.2017.35.15_suppl.e21657 | - |
dc.identifier.hkuros | 304305 | - |
dc.identifier.volume | 35 | - |
dc.identifier.issue | suppl. 15 | - |
dc.identifier.spage | abstract no. e21657 | - |
dc.identifier.epage | abstract no. e21657 | - |
dc.identifier.isi | WOS:000411932205190 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0732-183X | - |